CVE Database
/

CVE-2025-61940

Back to search

CVE-2025-61940

Published: Dec 2, 2025

Modified: Dec 9, 2025

PUBLISHED

CVSS v3.1

8.3

HIGH

Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

VendorProductVersions

Mirion Medical

EC2 Software NMIS BioDose

affected
0 - < 23.0
unaffected
23.0

Weaknesses (CWE)

CVSS v3.1 Details

CVSS v3.1 Vector

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L

Attack Vector

Network

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

Low

Security Training

Train your team to recognize and prevent security threats with our comprehensive security awareness program.

Start Training

Vulnerability Scanning

Discover vulnerabilities in your applications and infrastructure before attackers do.

Scan Now